Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial.

ABSTRACT:

SUBMITTER: Lewis DJ 

PROVIDER: S-EPMC12549478 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature